Prof. Dr. Ali Arıcan
Is this your profile? Claim it and verify your details.
Claim profilePerson ↔ Disease
Which diseases does this doctor work on?
-
Lymphoma, Non-Hodgkin 6 publicationsSource: OpenAlex / PubMed MeSHView publications
- Neoplasms 4 publications
- Sarcoma, Kaposi 4 publications
- Colorectal Neoplasms 3 publications
- Bone Neoplasms 3 publications
- Colonic Neoplasms 2 publications
- Rectal Neoplasms 2 publications
- Melanoma 2 publications
- Skin Neoplasms 2 publications
- Brain Neoplasms 2 publications
- Gastrointestinal Neoplasms 2 publications
- Breast Neoplasms 2 publications
- Leukemia-Lymphoma, Adult T-Cell 2 publications
Person ↔ Disease
Which topics does this doctor work on?
Medical areas of interest stated by the doctor on the institution profile. Source: acibadem.com.tr.
- Akciğer, Akciğer Zarı Kanserleri (Mezotelyoma) ve Diğer Torasik Kanserler
- Böbrek Kanseri
- Baş Boyun Kanserleri
- Kolorektal Kanserler (Kolon ve Rektum Kanseri)
- Meme Kanseri
- Mesane Kanseri
- Mide Kanseri
- Prostat Kanseri
- Yumurtalık (Over) Kanseri
- Testis Kanseri
- Gastrointestinal Onkoloji
- Akciğer Kanseri
- Kolon (Kalın Bağırsak) Kanseri
CV
Education and experience
Experience
- 2015Acıbadem Sağlık Grubuacibadem.com.tr
- 2009Mersin Üniversitesi Tıp Fakültesi İç Hastalıkları Anabilim Dalı / Profesöracibadem.com.tr
- 2009Mersin Üniversitesi Tıp Fakültesi İç Hastalıkları Anabilim Dalı / Öğretim Üyesiacibadem.com.tr
- 2008 - 2009İnönü Üniversitesi Tıp Fakültesi İç Hastalıkları Anabilim Dalı / Anabilim Dalı Başkanıacibadem.com.tr
- 2007 - 2009İnönü Üniversitesi Tıp Fakültesi / Tıbbi Onkoloji Bilim Dalı Kurucusu ve Başkanıacibadem.com.tr
- 2001 - 2007Sağlık Bakanlığı Ankara Etlik İhtisas Hastanesi / Tıbbi Onkoloji Kliniği Kurucusuacibadem.com.tr
- 1999 - 2001Başkent Üniversitesi Tıp Fakültesi / Tıbbi Onkoloji Bilim Dalı Kurucusu ve Başkan Vekilliğiacibadem.com.tr
- 1998 - 1999Başkent Üniversite Hastanesi İç Hastalıkları Anabilim Dalı / Tıbbi Onkoloji Uzmanıacibadem.com.tr
- ExperienceMersin Üniversitesi Tıp Fakültesi Tıbbi Onkoloji Bilim Dalı / Bilim Dalı Başkanıacibadem.com.tr
Education
- 2009İnönü Üniversitesi Tıp Fakültesi İç Hastalıkları Anabilim Dalı / Profesör, Digeracibadem.com.tr
- 2001Başkent Üniversite Hastanesi İç Hastalıkları Anabilim Dalı, Tıbbi Onkoloji Bilim Dalı / Doçent, Digeracibadem.com.tr
- 2000Başkent Üniversite Hastanesi İç Hastalıkları Anabilim Dalı, Tıbbi Onkoloji Bilim Dalı / Yardımcı Doçent, Digeracibadem.com.tr
- 1997Ankara Üniversitesi Tıp Fakültesi, Tıbbi Onkoloji, Üst Uzmanlıkacibadem.com.tr
- 1993Ankara Üniversitesi Tıp Fakültesi, İç Hastalıkları, Uzmanlıkacibadem.com.tr
- 1987Ankara Üniversitesi Tıp Fakültesi, Üniversiteacibadem.com.tr
Trust
Where does this information come from?
The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.
- SpecialtyMedical Oncologyacibadem.com.trFrom source
- InstitutionAcıbadem Atakent Hastanesiacibadem.com.trFrom source
- Area of workLymphoma, Non-HodgkinExtracted from 6 publications · Model version —From source
- Publications69 publicationsOpenAlexFrom source
- Last synchronised4 November 2026 20:50https://www.acibadem.com.tr/doktor/ali-arican/acibadem.com.tr
Scientific work
Publications on Lymphoma, Non-Hodgkin
-
Lenvatinib plus pembrolizumab in previously treated advanced endometrial cancer: 5-year outcomes from the randomized, phase 3 Study 309/KEYNOTE-775
Journal for ImmunoTherapy of Cancer, 2026
DOI 10.1136/jitc-2025-013713 PMID 41714113 2 citations (Europe PMC) Open-access full textSource: OpenAlex
-
Effect of Primary Breast Surgery on Prognosis in Breast Cancer Patients Presenting with Isolated Bone Metastases
Cancers, 2026
DOI 10.3390/cancers18111760 PMID 42279343 Open-access full textSource: OpenAlex
-
Comparison of prognoses in pancreatic cancer patients receiving neoadjuvant therapy versus adjuvant therapy.
Journal of Clinical Oncology, 2026
DOI 10.1200/jco.2026.44.16_suppl.e16451 Open-access full textSource: OpenAlex
-
Clinicopathological Characteristics and Survival Outcomes of Male Breast Lymphoma
Journal of Clinical Medicine, 2026
DOI 10.3390/jcm15187136 PMID 42795909 Open-access full textSource: OpenAlex
-
Evolving Concepts and Contemporary Management of Early-Stage Breast Cancer: An Evidence-Based Approach to Grey Zones from a Comprehensive Breast Unit Part 2: Systemic Treatment
European Journal of Breast Health, 2025
DOI 10.4274/ejbh.galenos.2025.2025-10-2 PMID 41447641 Open-access full textSource: OpenAlex
-
Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer
BMC Cancer, 2024
DOI 10.1186/s12885-023-11783-5 PMID 38166764 6 citations (Europe PMC) Open-access full textSource: OpenAlex
-
False-positive MRI Findings in Breast Cancer After Neoadjuvant Chemotherapy and Correlation Between Tumor Response Patterns and HER2 Status
Acta Oncologica Turcica, 2023
DOI 10.5505/aot.2023.60973 Source: OpenAlex
-
Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study.
Journal of Clinical Oncology, 2022
DOI 10.1200/jco.2022.40.4_suppl.202 Source: OpenAlex
-
Immunhistochemical Expression of Estrogen, Progesteron Receptors, C-Erb B-2, P53 and BRCA1 in Ovarian Carcinoma and Their Prognostic Value
Kahramanmaraş Sütçü İmam Üniversitesi Tıp Fakültesi Dergisi, 2021
DOI 10.17517/ksutfd.873338 Source: OpenAlex
-
Clinicopathological and prognostic significance of microsatellit instability (MSI) status and PDl-1 expression in Turkish patients with gastric cancer.
Journal of Clinical Oncology, 2019
DOI 10.1200/jco.2019.37.15_suppl.e15538 1 citation (OpenAlex) Source: OpenAlex